iShares Biotechnology ETF
Name
As of 04/25/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
-7.4%
1 yr return
-2.1%
3 Yr Avg Return
-7.2%
5 Yr Avg Return
3.5%
Net Assets
$7.63 B
Holdings in Top 10
58.7%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.45%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 46.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Name
As of 04/25/2024Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
IBB - Profile
Distributions
- YTD Total Return -7.4%
- 3 Yr Annualized Total Return -7.2%
- 5 Yr Annualized Total Return 3.5%
- Capital Gain Distribution Frequency Annually
- Net Income Ratio 0.21%
- Dividend Yield 0.4%
- Dividend Distribution Frequency Quarterly
Fund Details
-
Legal NameiShares Biotechnology ETF
-
Fund Family NameBlackRock-advised Funds
-
Inception DateFeb 05, 2001
-
Shares Outstanding64000000
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUS
-
ManagerGreg Savage
Fund Description
IBB - Performance
Return Ranking - Trailing
Period | IBB Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -7.4% | -29.9% | 12.8% | 90.80% |
1 Yr | -2.1% | -25.0% | 20.2% | 84.66% |
3 Yr | -7.2%* | -36.9% | 11.3% | 83.33% |
5 Yr | 3.5%* | -7.3% | 14.6% | 83.21% |
10 Yr | 5.6%* | 0.2% | 13.9% | 90.65% |
* Annualized
Return Ranking - Calendar
Period | IBB Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 3.5% | -12.6% | 19.0% | 40.49% |
2022 | -14.0% | -53.9% | 3.2% | 66.67% |
2021 | 0.7% | -39.6% | 24.2% | 47.44% |
2020 | 25.7% | -13.6% | 178.2% | 16.56% |
2019 | 25.0% | 3.8% | 63.8% | 25.19% |
Total Return Ranking - Trailing
Period | IBB Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | -7.4% | -29.9% | 12.8% | 90.80% |
1 Yr | -2.1% | -25.0% | 20.2% | 84.66% |
3 Yr | -7.2%* | -36.9% | 11.3% | 83.33% |
5 Yr | 3.5%* | -7.3% | 14.6% | 83.21% |
10 Yr | 5.6%* | 0.2% | 13.9% | 90.65% |
* Annualized
Total Return Ranking - Calendar
Period | IBB Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | 3.8% | -12.6% | 19.0% | 57.67% |
2022 | -13.7% | -53.9% | 3.7% | 75.64% |
2021 | 1.0% | -33.9% | 26.0% | 78.21% |
2020 | 26.0% | -0.7% | 180.6% | 37.09% |
2019 | 25.2% | 4.6% | 63.8% | 56.30% |
IBB - Holdings
Concentration Analysis
IBB | Category Low | Category High | IBB % Rank | |
---|---|---|---|---|
Net Assets | 7.63 B | 7.41 M | 47.2 B | 9.20% |
Number of Holdings | 231 | 23 | 413 | 3.07% |
Net Assets in Top 10 | 4.38 B | 2.19 M | 20.5 B | 4.91% |
Weighting of Top 10 | 58.69% | 18.1% | 77.0% | 12.27% |
Top 10 Holdings
- BlackRock Cash Funds: Institutional, SL Agency Shares 10.50%
- Vertex Pharmaceuticals, Inc. 8.50%
- Amgen, Inc. 7.92%
- Regeneron Pharmaceuticals, Inc. 7.90%
- Gilead Sciences, Inc. 7.84%
- IQVIA Holdings, Inc. 4.01%
- Biogen, Inc. 3.73%
- Moderna, Inc. 3.30%
- Mettler-Toledo International, Inc. 2.59%
- Alnylam Pharmaceuticals, Inc. 2.39%
Asset Allocation
Weighting | Return Low | Return High | IBB % Rank | |
---|---|---|---|---|
Stocks | 99.83% | 87.17% | 106.13% | 16.56% |
Cash | 10.67% | 0.00% | 32.99% | 9.20% |
Other | 0.00% | -22.99% | 17.73% | 31.90% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 55.21% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 41.14% |
Bonds | 0.00% | 0.00% | 12.39% | 42.94% |
Stock Sector Breakdown
Weighting | Return Low | Return High | IBB % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 19.62% |
Utilities | 0.00% | 0.00% | 0.00% | 36.71% |
Technology | 0.00% | 0.00% | 22.69% | 41.77% |
Real Estate | 0.00% | 0.00% | 5.89% | 40.51% |
Industrials | 0.00% | 0.00% | 7.02% | 41.14% |
Financial Services | 0.00% | 0.00% | 1.60% | 54.43% |
Energy | 0.00% | 0.00% | 0.00% | 36.71% |
Communication Services | 0.00% | 0.00% | 9.11% | 39.87% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 45.57% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 41.14% |
Basic Materials | 0.00% | 0.00% | 7.16% | 57.59% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | IBB % Rank | |
---|---|---|---|---|
US | 99.83% | 66.21% | 104.41% | 14.11% |
Non US | 0.00% | 0.00% | 28.58% | 71.78% |
IBB - Expenses
Operational Fees
IBB Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.45% | 0.08% | 4.28% | 88.34% |
Management Fee | 0.45% | 0.03% | 1.25% | 12.88% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
IBB Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 3.50% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
IBB Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
IBB Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 46.00% | 0.00% | 238.00% | 44.93% |
IBB - Distributions
Dividend Yield Analysis
IBB | Category Low | Category High | IBB % Rank | |
---|---|---|---|---|
Dividend Yield | 0.40% | 0.00% | 6.25% | 30.67% |
Dividend Distribution Analysis
IBB | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Quarterly | Annual | Annual | Annual |
Net Income Ratio Analysis
IBB | Category Low | Category High | IBB % Rank | |
---|---|---|---|---|
Net Income Ratio | 0.21% | -2.54% | 1.85% | 25.64% |
Capital Gain Distribution Analysis
IBB | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Annually | Annually | Annually |
Distributions History
Date | Amount | Type |
---|---|---|
Mar 27, 2024 | $0.126 | OrdinaryDividend |
Dec 27, 2023 | $0.124 | OrdinaryDividend |
Oct 02, 2023 | $0.153 | OrdinaryDividend |
Jun 13, 2023 | $0.006 | OrdinaryDividend |
Mar 29, 2023 | $0.065 | OrdinaryDividend |
Dec 19, 2022 | $0.101 | OrdinaryDividend |
Sep 30, 2022 | $0.159 | OrdinaryDividend |
Jun 15, 2022 | $0.031 | OrdinaryDividend |
Mar 30, 2022 | $0.118 | OrdinaryDividend |
Dec 17, 2021 | $0.041 | OrdinaryDividend |
Sep 30, 2021 | $0.124 | OrdinaryDividend |
Jun 16, 2021 | $0.023 | OrdinaryDividend |
Mar 31, 2021 | $0.131 | OrdinaryDividend |
Dec 18, 2020 | $0.066 | OrdinaryDividend |
Sep 29, 2020 | $0.063 | OrdinaryDividend |
Jun 19, 2020 | $0.127 | OrdinaryDividend |
Mar 31, 2020 | $0.055 | OrdinaryDividend |
Dec 20, 2019 | $0.058 | OrdinaryDividend |
Sep 30, 2019 | $0.072 | OrdinaryDividend |
Jun 21, 2019 | $0.080 | OrdinaryDividend |
Oct 02, 2018 | $0.032 | OrdinaryDividend |
Jul 02, 2018 | $0.156 | OrdinaryDividend |
Dec 28, 2017 | $0.125 | OrdinaryDividend |
Sep 29, 2017 | $0.040 | OrdinaryDividend |
Jun 30, 2017 | $0.059 | OrdinaryDividend |
Mar 30, 2017 | $0.100 | OrdinaryDividend |
Dec 29, 2016 | $0.031 | OrdinaryDividend |
Sep 30, 2016 | $0.029 | OrdinaryDividend |
Jun 27, 2016 | $0.054 | OrdinaryDividend |
Mar 30, 2016 | $0.051 | OrdinaryDividend |
Dec 31, 2015 | $0.011 | OrdinaryDividend |
Oct 01, 2015 | $0.001 | OrdinaryDividend |
Jun 30, 2015 | $0.019 | OrdinaryDividend |
Sep 30, 2014 | $0.018 | OrdinaryDividend |
Jul 01, 2014 | $0.131 | OrdinaryDividend |
Jul 03, 2013 | $0.024 | OrdinaryDividend |
Dec 26, 2012 | $0.034 | OrdinaryDividend |
Sep 28, 2012 | $0.113 | OrdinaryDividend |
Jun 28, 2012 | $0.062 | OrdinaryDividend |
Mar 29, 2012 | $0.009 | OrdinaryDividend |
Dec 29, 2011 | $0.005 | OrdinaryDividend |
Sep 30, 2010 | $0.170 | OrdinaryDividend |
Jun 30, 2008 | $0.059 | OrdinaryDividend |
Jul 06, 2007 | $0.030 | OrdinaryDividend |
IBB - Fund Manager Analysis
Managers
Greg Savage
Start Date
Tenure
Tenure Rank
Jan 01, 2008
14.42
14.4%
Greg Savage, Managing Director; has been associated with BlackRock Fund Advisors since 2009. Mr. Savage has been a senior portfolio manager for BFA and BTC since 2009. Prior to his employment with BFA and BTC, Mr. Savage was a senior portfolio manager from 2006 to 2009 for BGFA and BGI and a portfolio manager from 2001 to 2006 for BGFA and BGI.
Jennifer Hsui
Start Date
Tenure
Tenure Rank
Aug 01, 2012
9.84
9.8%
Jennifer Hsui, Managing Director & Portfolio Manager at BlackRock Investment Management LLC has been employed by BlackRock Fund Advisors as a senior portfolio manager since 2007. Prior to that, Ms. Hsui was a portfolio manager from 2006 to 2007 for BGFA. She was a research analyst for RBC Capital Markets from 2003 to 2006.
Amy Whitelaw
Start Date
Tenure
Tenure Rank
Aug 01, 2018
3.83
3.8%
Amy Whitelaw is Managing Director of BlackRock, Inc. since 2013 and was Director of the firm from 2009 to 2012. Ms. Whitelaw's service with the firm dates back to 1998, including her years with Barclays Global Investors (BGI), which merged with BlackRock in 2009. Ms. Whitelaw served as Principal of BGI from 2000 to 2009. Previously Ms. Whitelaw worked in the Transition Services group as a transition manager and strategist, and was also an international equity trader on BGI’s trading desk.
Paul Whitehead
Start Date
Tenure
Tenure Rank
Jan 01, 2022
0.41
0.4%
Paul Whitehead is responsible for supporting the day-to-day management of the MML Blend Fund’s portfolio, including setting the Fund’s overall investment strategy and overseeing the management of the Fund. Mr. Whitehead is a Managing Director of BlackRock, Inc., Co-Head of Index Equity, and Co-Head of BlackRock’s ETF and Index Investments business. Mr. Whitehead also oversees the management of BlackRock’s Institutional and iShares funds. Mr. Whitehead was previously the Global Head of Equity Trading and the Global Head of Transition Management within BlackRock’s Global Trading Group. Mr. Whitehead’s service with the firm dates back to 1996, including his years with Barclays Global Investors, which merged with BlackRock in 2009. Prior to his current role, Mr. Whitehead was Head of Americas Equity Trading. Previously, he managed the trading team responsible for all Institutional Index funds, Exchange Traded funds, and Transition Management mandates. Mr. Whitehead represents BlackRock on the board of Luminex, a buy-side owned Alternative Trading System launched in 2015.
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.84 | 0.25 |